Nitrolingual (Glyceryl Trinitrate)

• Nitrolingual, a nitrate vasodilator, is employed in the management of coronary‑related chest pain conditions.
• Acute angina pectoris: rapid relief of chest pain episodes.
• Prophylaxis of angina attacks: reduces frequency of angina episodes.
• Coronary artery spasm (variant angina): alleviates pain caused by transient coronary vasoconstriction.

• Glyceryl trinitrate acts as a nitric oxide donor. Once administered sublingually, it is converted to nitric oxide, which activates guanylate cyclase in vascular smooth muscle, increasing cyclic GMP levels. Elevated cGMP leads to relaxation of coronary and peripheral vessels, decreasing myocardial oxygen demand and improving blood flow to the heart.

Nitrolingual may cause a range of adverse reactions, most of which are dose‑related and transient.

Common Side Effects

• Headache: throbbing pain often occurring shortly after administration.
• Flushing: warm sensation and redness of the skin.
• Dizziness or light‑headedness: due to transient blood pressure fall.
• Hypotension: mild to moderate reduction in blood pressure.
• Nausea: occasional upset stomach.
• Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Syncope: fainting episodes.
• Myocardial infarction: rare but possible in patients with severe coronary disease.
• Allergic reaction: rash, itching, or swelling.
• Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

• Before prescribing Nitrolingual, clinicians should consider several safety aspects.
• Assess cardiovascular status: confirm diagnosis of angina and evaluate blood pressure.
• Avoid concomitant nitrates: concurrent use can cause profound hypotension.
• Monitor blood pressure: check for excessive drops after dosing.
• Use caution in anemia or hypovolemia: patients may be more sensitive to vasodilation.
• Do not discontinue abruptly: sudden cessation may precipitate rebound angina.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Nitrolingual can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of severe hypotension.
• Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect.
• Riociguat: potentiates nitric oxide pathway leading to dangerous blood pressure fall.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents (e.g., ACE inhibitors, ARBs): may enhance blood pressure reduction.
• Beta‑blockers: combined effect on heart rate and blood pressure.
• Calcium channel blockers: possible additive hypotensive effect.